A detailed history of Private Advisor Group, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 27,861 shares of PACB stock, worth $53,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,861
Previous 27,718 0.52%
Holding current value
$53,771
Previous $37,000 27.03%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$1.2 - $2.17 $171 - $310
143 Added 0.52%
27,861 $47,000
Q2 2024

Aug 05, 2024

BUY
$1.36 - $3.65 $3,243 - $8,705
2,385 Added 9.41%
27,718 $37,000
Q1 2024

Apr 30, 2024

BUY
$3.52 - $9.59 $20,915 - $56,983
5,942 Added 30.64%
25,333 $94,000
Q4 2023

Feb 06, 2024

SELL
$5.97 - $10.36 $2,083 - $3,615
-349 Reduced 1.77%
19,391 $190,000
Q3 2023

Nov 02, 2023

BUY
$8.23 - $13.93 $16,682 - $28,236
2,027 Added 11.44%
19,740 $164,000
Q2 2023

Aug 09, 2023

BUY
$9.97 - $14.05 $43,887 - $61,848
4,402 Added 33.07%
17,713 $235,000
Q1 2023

May 10, 2023

BUY
$7.94 - $12.02 $3,970 - $6,010
500 Added 3.9%
13,311 $154,000
Q4 2022

Jan 18, 2023

SELL
$5.67 - $11.2 $5,103 - $10,080
-900 Reduced 6.56%
12,811 $0
Q3 2022

Oct 14, 2022

SELL
$3.93 - $8.57 $5,729 - $12,495
-1,458 Reduced 9.61%
13,711 $80,000
Q2 2022

Jul 13, 2022

SELL
$4.02 - $10.43 $17,595 - $45,652
-4,377 Reduced 22.39%
15,169 $67,000
Q1 2022

May 12, 2022

BUY
$8.43 - $20.9 $497 - $1,233
59 Added 0.3%
19,546 $178,000
Q4 2021

Feb 10, 2022

BUY
$19.26 - $30.08 $63,558 - $99,264
3,300 Added 20.39%
19,487 $399,000
Q3 2021

Oct 14, 2021

SELL
$24.86 - $35.02 $9,944 - $14,008
-400 Reduced 2.41%
16,187 $414,000
Q2 2021

Aug 12, 2021

SELL
$22.3 - $36.02 $18,977 - $30,653
-851 Reduced 4.88%
16,587 $580,000
Q1 2021

Apr 22, 2021

BUY
$26.38 - $51.15 $67,321 - $130,534
2,552 Added 17.14%
17,438 $581,000
Q4 2020

Apr 01, 2021

BUY
$10.5 - $28.5 $5,943 - $16,131
566 Added 3.95%
14,886 $386,000
Q3 2020

Nov 02, 2020

BUY
$3.61 - $9.87 $27,995 - $76,541
7,755 Added 118.13%
14,320 $141,000
Q2 2020

Aug 17, 2020

BUY
$2.65 - $4.03 $17,397 - $26,456
6,565 New
6,565 $23,000
Q4 2019

Feb 10, 2020

SELL
$4.6 - $5.57 $46,000 - $55,700
-10,000 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$4.99 - $6.16 $49,900 - $61,600
10,000 New
10,000 $52,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.